Showing results (1-10 of 22) with videos related to
Sort By:
Pageof 3
BMC Health Services Research|July 24, 2020
The use of UK primary care databases in health technology assessments carried out by the National Institute for health and care excellence (NICE)Thomas P Leahy, Sreeram Ramagopalan, Cormac SammonJournal of Comparative Effectiveness Research|March 10, 2020
Approaches for the identification of chronic kidney disease in CPRD-HES-linked studiesSreeram Ramagopalan, Thomas P Leahy, Elaine Stamp, et al.Therapie|April 5, 2014
The Clinical Practice Research Datalink for drug safety in pregnancy research: an overviewRachel Charlton, Julia Snowball, Cormac Sammon, et al.BMJ Open|July 13, 2016
Diagnosis and management of polycystic ovary syndrome in the UK (2004-2014): a retrospective cohort studyTao Ding, Gianluca Baio, Paul J Hardiman, et al.BMJ Open|October 25, 2023
Estimating the prevalence of diagnosed Alzheimer disease in England across deprivation groups using electronic health records: a clinical practice research datalink studyThomas Patrick Leahy, Alex Simpson, Cormac Sammon, et al.Future Science OA|January 13, 2021
Derivation of DO-BITS, a score for predicting success on Love Island: a retrospective, observational cohort studyAlex Simpson, Sophie Graham, Cormac Sammon, et al.BMC Medicine|September 15, 2021
The value of innovation: association between improvements in survival of advanced and metastatic non-small cell lung cancer and targeted and immunotherapySreeram Ramagopalan, Thomas P Leahy, Joshua Ray, et al.Journal of Comparative Effectiveness Research|October 23, 2020
Comparative effectiveness of trastuzumab emtansine versus lapatinib plus chemotherapy for HER2+ metastatic breast cancerSreeram V Ramagopalan, Riccardo Pisoni, Aleksandr Zenin, et al.Age and Ageing|April 4, 2020
Factors associated with non-prescription of oral anticoagulant treatment in non-valvular atrial fibrillation patients with dementia: a CPRD-HES studyMegan Besford, Sophie Graham, Cormac Sammon, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 18, 2024
Acceptability of Using Real-World Data to Estimate Relative Treatment Effects in Health Technology Assessments: Barriers and Future StepsManuel Gomes, Alex J Turner, Cormac Sammon, et al.Pageof 3